|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 15,42 USD | -6,63% |
|
-29,43% | +1,53% |
| 31/07 | Aandelen Novo Nordisk kelderen nadat kandidaat-medicijn tegen hartziekten faalt in laat stadium van onderzoek | MT |
| 31/07 | MONTE ROSA THERAPEUTICS, INC. : Wedbush herhaalt koopadvies | ZM |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6,63% | -29,43% | -31,53% | -18,65% | +1,53% | +226,23% | +136,90% | -42,36% | - | 1,4 mld. | |
| -0,36% | +0,14% | -2,44% | +16,90% | +4,17% | -0,95% | +14,33% | -22,13% | +207,63% | 48,53 mld. | |
| -2,65% | -2,45% | -3,44% | +24,04% | +130,33% | +393,44% | +475,29% | +521,69% | - | 39,87 mld. | |
| -0,79% | +8,86% | +12,69% | +44,22% | +2,97% | +27,01% | +7,31% | -7,15% | +201,28% | 38,68 mld. | |
| -1,60% | -4,66% | +0,40% | +4,57% | +2,27% | +2,11% | +50,96% | -9,00% | +1.068,52% | 35,13 mld. | |
| -2,41% | +2,59% | +3,17% | -4,58% | +5,70% | +11,68% | +41,16% | -15,90% | +153,21% | 29,79 mld. | |
| +0,23% | -2,65% | +1,53% | +37,58% | +2,15% | +32,67% | +122,34% | +224,80% | - | 16,11 mld. | |
| +0,48% | -4,11% | -9,30% | +6,25% | - | - | - | - | - | 16,08 mld. | |
| -0,62% | +1,23% | -2,34% | +17,08% | +8,56% | +1,80% | +15,05% | -33,78% | +80,78% | 13,61 mld. | |
| -2,49% | -7,17% | -8,34% | +39,93% | -14,02% | -4,93% | -37,59% | -35,81% | +106,48% | 12,62 mld. | |
| +0,06% | +0,71% | +1,70% | +31,76% | +22,64% | +31,42% | -10,97% | -40,05% | +156,10% | 11,23 mld. | |
| -0,80% | +2,80% | -0,37% | +33,81% | +15,59% | +37,32% | +14,41% | -43,93% | +168,24% | 11,2 mld. | |
| +0,94% | -5,21% | -20,52% | +7,19% | -10,88% | +75,33% | +540,98% | +270,00% | +2.491,79% | 10,54 mld. | |
| -0,00% | -0,13% | +0,45% | +60,50% | +77,66% | +260,10% | +534,94% | - | - | 10,07 mld. | |
| -1,98% | -6,38% | +23,91% | +23,06% | +26,87% | +19,83% | +28,50% | -60,84% | - | 9,09 mld. | |
| -3,01% | -1,14% | +1,91% | +34,66% | +53,44% | +148,96% | +621,67% | +172,06% | - | 8,79 mld. | |
| +3,84% | -4,97% | -36,07% | -29,52% | -32,78% | +22,39% | +34,91% | +40,65% | +40,95% | 8,6 mld. | |
| -1,50% | -4,21% | -3,51% | -10,40% | +2,63% | +492,07% | +1.952,73% | +36,07% | - | 8,58 mld. | |
| +1,94% | +1,96% | +6,99% | +23,34% | -11,52% | -20,81% | -19,53% | -28,51% | +35,90% | 8,56 mld. | |
| -3,13% | -8,71% | -12,45% | +20,19% | +29,12% | +130,12% | +320,73% | +67,45% | - | 8,51 mld. | |
| Gemiddelde | -0,93% | -2,33% | -3,88% | +18,10% | +16,65% | +99,25% | +254,95% | +55,18% | +428,26% | 17,35 mld. | |
| Gewogen gemiddelde per kap. | -1,00% | +0,53% | -0,90% | +19,86% | +22,48% | +87,42% | +185,25% | +78,42% | +406,87% |
- Beurs
- Aandelen
- Koers GLUE
- Sector Monte Rosa Therapeutics, Inc.
Kies jouw editie
Alle financiële informatie op nationaal niveau
